πŸ‡ΊπŸ‡Έ FDA
Patent

US 7754739

Modulators of CFTR

granted A61PA61P25/00A61P27/02

Quick answer

US patent 7754739 (Modulators of CFTR) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jul 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61P, A61P25/00, A61P27/02, A61P3/00, A61P37/00